MCI researchers present their latest achievements in international AOS congress 2024

According to the Public Relations Department of MCI, the AOS 2024 International Congress, one of the most comprehensive and prestigious scientific events in the field of oncology, was held in Xi'an, China, from November 15 to 17, 2024. With the participation of leading experts around the world, this congress provided an opportunity to exchange new scientific achievements and findings in the field of cancer and advanced treatment methods.

MCI as one of the leading representatives of Iran in the field of cancer research and treatment, will have a great influential presence at the congress this year. Professor Ghavamzadeh, a permanent board member of the AOS and the prominent scientific figure in the field of hematology and oncology, along with a group of experts from MCI, participated in this grand event and presented their research findings and achievements.

The MCI team participated in AOS-2024 event consisted of Professor Ardeshir Ghavamzadeh, Dr. Ahmad Fazilat, Dr. Solaleh Aminian, Dr. Fatemeh Yadegari, Dr. Farkhonde Hasannejad, and Dr. Zahra Sadat Hashemi.

The active and effective presence of Motamed Cancer Research Institute at the AOS 2024 Congress does not only strengthen Iran’s scientific position in the field of hematology and oncology, but also contribute to creating opportunities for further international cooperation and knowledge exchange with other researchers and experts from different countries.